MANILA, Philippines — The Food and Drug Administration (FDA) is now looking into thealleged inaction of one of its offices on more than 600 drug applications of various pharmaceutical companies.
FDA Director General Eric Domingo made the remark Wednesday after the Anti-Red Tape Authority (ARTA) issued a show-cause order against FDA Center for Drug Regulation and Research (CDRR) Director IV Jesusa Joyce Cirunay asking her to explain why no administrative or criminal case should be filed against her over the alleged delays in processing the applications.
“‘Yung aming legal service namin ngayon ay tumutulong na rin na i-trace itong mga applications na ito para malaman kung may p…
Keep on reading: FDA looking into alleged delays in drug applications